A meta-analytic dataset on psilocybin-assisted therapies for adults with depressive symptoms, part of the Metapsy project, compares psilocybin therapy against control conditions. Effect sizes are reported for post-test and long-term follow-up outcomes. Data were independently extracted by two researchers, and risk of bias was assessed using the Cochrane Risk of Bias Tool (Version 2). The dataset is maintained by the Sypres Collaboration and follows the Metapsy data standard.
A meta-analytic dataset on psilocybin-assisted therapies for adults with depressive symptoms is described. It compares psilocybin therapy against control conditions, providing effect sizes for outcomes at post-test and long-term follow-ups. The dataset follows the Metapsy data standard, with information independently extracted by two researchers and risk of bias assessed using the Cochrane Collaboration Risk of Bias Tool (Version 2). It is part of the living Sypres Collaboration database.
A meta-analytic research dataset on psilocybin-assisted therapies for adults with depressive symptoms has been created as part of the Metapsy project. The dataset includes comparisons of psilocybin therapy against control conditions, with effect sizes for outcomes at post-test and long-term follow-ups. Information was independently extracted by two researchers, and risk of bias was assessed using the Cochrane Risk of Bias Tool (Version 2).